Navigation Links
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Date:1/23/2013

83

Table 49: Infectious Immunology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 85

Table 50: Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 87

Table 51: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 89

Table 52: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 91

Table 53: Retroviruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 92

Table 54: Retroviruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 93

Table 55: Hepatitis Viruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 94

Table 56: Hepatitis Viruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 95

Table 57: Other Virology, China, Revenue ($m), USD Constant, Historic, 2004-2011 96

Table 58: Other Virology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 97

Table 59: Bacteriology, China, Revenue ($m), USD Constant, Historic, 2004-2011 98

Table 60: Bacteriology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 99

Table 61: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 101

Table 62: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 103

Table 63: Infectious Immunology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 104

Table 64: Infectious Immunology, China, Company Share by Revenue ($m), USD Constant, 2010-2011 106

Table 65: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 108

Table 66: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 110

Table 67: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 112

Table 68: Retroviruses, South Africa, Revenue ($m), USD Co
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
2. US Lab Deployed to Boost Mexicos Response to Outbreaks of Infectious Disease
3. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
4. Soligenix Announces Collaboration with Infectious Disease Research Institute to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants
5. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
6. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
7. Frost & Sullivan: Asia Pacific Infectious Disease Diagnostics Market Grows as Economies Boom and Countries Become Image Conscious
8. Synthetic Biologics to Acquire Clinical-Stage C. difficile Infectious Disease Program
9. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
10. Avery-Landsteiner Prize for Immunology Awarded to Alain Fischer of Paris, France, by German Society for Immunology
11. Immunology 2013™ Travel Grants Available from R&D Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... (PRWEB) April 16, 2015 Proove ... Buzz of BIO Contest for the 2015 ... (BIO), the 2015 BIO International Convention will take place ... Pennsylvania. During the Buzz of BIO contest, industry leaders ... see present at the conference. The community voting period ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... ROCKVILLE, Md. , April 16, 2015 /PRNewswire/ ... "RegeneRx") today announced its U.S. joint venture with ... conduct a phase 3 clinical trial for the ... dose-response, confirmatory trial for dry eye syndrome (DES) ... ReGenTree,s preservative-free eye drops, RGN-259/GBT201, this year.  Each ...
(Date:4/16/2015)... , April 16, 2015  AnaptysBio, Inc., ... of therapeutic antibodies, today announced the advancement ... program into IND-enabling studies. The Company,s anti-IL-36R ... treatment for generalized pustular psoriasis (GPP), an ... medical need. ANB019 is wholly owned within AnaptysBio,s ...
Breaking Biology Technology:Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2
... Inc. (Nasdaq: TSRX ) announced today that Jeffrey ... will participate in a panel discussion on antibiotic drug development ... to Kill Superbugs: Novel Antibiotics to Hit Drug Resistant Bacteria, ... 5th at the Westin Waterfront Hotel in Boston. ...
... (Nasdaq: OREX ), a biopharmaceutical company focused ... of its upcoming Contrave® (naltrexone sustained release (SR)/bupropion SR) ... of The Obesity Society. This meeting will be held ... October 10:  Embargo Lifts October 10 at 12:30 p.m. ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced ... Annual BIO Investor Forum on Wednesday, October 6 at 10:30 ... Live webcasts from this conference will be available ... at http://ir.oncogenex.com . Webcast replays will be available approximately ...
Cached Biology Technology:Orexigen® Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society 2OncoGenex Pharmaceuticals to Present at the 9th Annual BIO Investor Forum 2
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
(Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... have wondered why ovarian cancer cells are so attracted ... hope that such an understanding could lead to better ... series of experiments suggest a two-step model of omental ... and lodge within immune cell-containing structures known as milky ...
... 2013 http://www.researchandmarkets.com/research/xmlpcb/siliconbased has ... Sensors - Global Strategic Business Report " report ... This report analyzes the worldwide markets ... Million by the following Types: Swipe Sensors and ...
... team led by William Fenical at Scripps Institution of ... chemical compound from an ocean microbe in a preliminary ... for new treatments for anthrax and other ailments such ... reported in the international edition of the German journal ...
Cached Biology News:Ovarian cancer metastases influenced by factors in target tissues 2Ovarian cancer metastases influenced by factors in target tissues 3Silicon-based Fingerprint Sensors - Global Strategic Business Report 2Silicon-based Fingerprint Sensors - Global Strategic Business Report 3Compound discovered at sea shows potency against anthrax 2
Form: Ready to use Applications: Western Blot, ELISA...
This kit only detects beta-galactosidase activity at pH 6 in cultured cells andtissue sections. Beta-galactosidase activity at pH 6 ispresent only in senescent cells, and is not found inpresenescent...
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
FRACTALKINE [Human] (Recombinant)...
Biology Products: